Yau et al reported the Hong Kong Liver Cancer Staging System for patients with hepatocellular carcinoma. The stage can help guide patient management. The authors are from the Univeristy of Hong Kong.
Parameters:
(1) ECOG and Child stage
(2) extrahepatic vascular invasion and/or metastasis (EVM)
(3) tumor status
ECOG and Child |
EVM |
Tumor Status |
Stage |
ECOG 0, Child A |
absent |
early |
I |
ECOG 1 or Child B |
absent |
early |
IIa |
ECOG 0 or 1, Child A |
absent |
intermediate |
IIb |
ECOG 0 or 1, Child B |
absent |
intermediate |
IIIa |
ECOG 0 or 1, Child A or B |
absent |
locally advanced |
IIIb |
ECOG 0 or 1, Child A |
present |
NA |
IVa |
ECOG 0 or 1, Child B |
present |
NA |
IVb |
ECOG 2 to 4, or Child C |
absent |
early |
Va |
ECOG 2 to 4, or Child C |
other |
other |
Vb |
Early status - all of the following:
(1) diameter <= 5 cm, 1 to 3 tumor nodules and no intrahepatic venous invasion
Intermediate status:
(1) diameter <= 5 cm, >= 4 tumor nodules, without intrahepatic venous invasion
(2) diameter <= 5 cm, 1 to 3 tumor nodules, with intrahepatic venous invasion)
(3) diameter > 5 cm, 1 to 3 tumor nodules, and no intrahepatic venous invasion
Locally advanced:
(1) diameter <= 5 cm, >= 4 tumor nodules, and intrahepatic venous invasion
(2) diameter > 5 cm, >= 4 tumor nodules, without intrahepatic venous invasion
(3) diameter > 5 cm, >= 4 tumor nodules, with intrahepatic venous invasion
(4) diameter > 5 cm, 1 to 3 tumor nodules, with intrahepatic venous invasion
(5) diffuse tumor
Diameter |
Number |
IH Venous Invasion |
Status |
<= 5 cm |
1 to 3 |
absent |
early |
<= 5 cm |
1 to 3 |
present |
intermediate |
<= 5 cm |
>= 4 |
absent |
intermediate |
> 5 cm |
1 to 3 |
absent |
intermediate |
<= 5 cm |
>= 4 |
present |
locally advanced |
> 5 cm |
>= 4 |
absent |
locally advanced |
> 5 cm |
1 to 3 |
present |
locally advanced |
> 5 cm |
>= 4 |
present |
locally advanced |
Stage |
Management |
I |
resection, liver transplant, ablation |
IIa |
resection, liver transplant, ablation |
IIb |
resection |
IIIa |
TACE |
IIIb |
TACE |
IVa |
systemic therapy |
IVb |
systemic therapy, supportive care |
Va |
liver transplant |
Vb |
supportive care |
Specialty: Hematology Oncology, Gastroenterology